International Business News - CELG http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the earnings stories for Thursday, July 24, from AP Financial News: NEW YORK (AP)--Newspaper publisher McClatchy Co.'s second-quarter earnings tumbled 44 percent as ad revenue continued to shrink in its key markets. http://www.ibtimes.com/articles/20080724/earnings-roundup-mcclatchy-charlotte-russe.htm Thu, 24 Jul 2008 14:28:39 EDT Among the earnings projection stories for Thursday, July 24, from AP Financial News: SUMMIT, N.J. (AP)--Biotechnology company Celgene Corp. raised its full-year profit and revenue outlook Thursday after reporting a surge in second-quarter sales from its key cancer drug Revlimid. http://www.ibtimes.com/articles/20080724/outlook-roundup-celgene-becton-dickinson.htm Thu, 24 Jul 2008 14:18:18 EDT Wall Street has so far dealt with a mixed second-quarter report card for biotechnology companies, but shares continue outpacing the broader market on a mix of positive sales results and a bright outlook for buyout potential within the sector. http://www.ibtimes.com/articles/20080724/sector-snap-biotech-outpaces-the-market.htm Thu, 24 Jul 2008 12:49:12 EDT Biotechnology company Celgene Corp. raised its full-year profit and revenue outlook Thursday after reporting a surge in second-quarter sales from its key cancer drug Revlimid. http://www.ibtimes.com/articles/20080724/celgene-boosts-2008-outlook-on-cancer-drug-sales.htm Thu, 24 Jul 2008 11:27:45 EDT Biotechnology company Celgene Corp. said Thursday its second-quarter profit more than doubled on a surge in sales of the cancer drug Revlimid. For the quarter ended June 30, the company earned $119.9 million, or 26 cents per share, compared with a profit of $54.9 million, or 13 cents per share, in the year-ago period. Excluding charges mostly related to the buyout of Pharmion Corp. in March, the company said it earned 37 cents per share. http://www.ibtimes.com/articles/20080724/celgenes-2q-profit-doubles-on-cancer-drug-sales.htm Thu, 24 Jul 2008 10:41:01 EDT Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the year. http://www.ibtimes.com/articles/20080721/sector-snap-biotech-stocks-rise-on-buyout-offer.htm Mon, 21 Jul 2008 11:42:39 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080711/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Fri, 11 Jul 2008 05:28:20 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080710/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Thu, 10 Jul 2008 17:32:34 EDT Biotech companies will likely be one of the few bright spots for investors this earnings season, as demand for essential medical treatments continues unabated despite the economic slowdown. http://www.ibtimes.com/articles/20080709/market-spotlight-biotechnology-earnings-preview.htm Wed, 09 Jul 2008 13:10:45 EDT The Nasdaq 100 index rose Tuesday as shares of biopharmaceutical company Celgene Corp. advanced after competitor SuperGen Inc.'s bone marrow cancer drug Dacogen failed a late-stage European study. http://www.ibtimes.com/articles/20080701/nasdaq-100-leaders-and-laggards-celg-uaua.htm Tue, 01 Jul 2008 16:45:37 EDT Among the stock activity stories for Tuesday, July 1, from AP Financial News: NEW YORK (AP)--Shares of Capital One Financial Corp. rose Tuesday after an analyst upgraded the credit card company, saying recent dips in valuation now largely reflect the difficult operating environment. http://www.ibtimes.com/articles/20080701/movers-roundup-capital-one-smithfield.htm Tue, 01 Jul 2008 15:21:23 EDT The Standard & Poor's 500 declined in midday trading on Tuesday, with the biggest fall taken by shares of Fortune Brands Inc., after the company lowered its outlook. http://www.ibtimes.com/articles/20080701/midday-leaders-laggards-s-p-500.htm Tue, 01 Jul 2008 12:24:05 EDT Shares of biotechnology company Celgene Corp. advanced Tuesday as a potential competitor to its bone-marrow cancer treatment in Europe failed a late-stage clinical trial. http://www.ibtimes.com/articles/20080701/celgene-shares-rise-as-rivals-drug-fails-study.htm Tue, 01 Jul 2008 18:43:15 EDT The Nasdaq 100 index rose slightly in midday trading Tuesday as the broader markets fluctuated and investors scrutinized a report showing fuel prices continue to lambast the manufacturing sector. http://www.ibtimes.com/articles/20080701/midday-leaders-and-laggards-nasdaq-100.htm Tue, 01 Jul 2008 12:08:01 EDT SuperGen Inc. said Tuesday its bone marrow disorder drug Dacogen failed in a late-stage European clinical trial, which pressured SuperGen shares and boosted Celgene Corp., which makes a rival drug, Vidaza. http://www.ibtimes.com/articles/20080701/out-of-the-gate-supergen-drug-trial-fails.htm Tue, 01 Jul 2008 10:46:34 EDT The Nasdaq 100 index slipped in midday trading Friday as the markets wobbled on record-high oil prices, a weak consumer sentiment reading and a government report showing personal spending rose in May. http://www.ibtimes.com/articles/20080627/midday-leaders-and-laggards-nasdaq-100.htm Fri, 27 Jun 2008 12:23:44 EDT Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesday. http://www.ibtimes.com/articles/20080624/sector-snap-biotech-_-large-cap-or-small-cap.htm Tue, 24 Jun 2008 12:51:24 EDT Patients deferring hospital procedures, the challenges facing managed care companies, and biotechnology pipelines will be among the themes discussed at the Jefferies health care conference, which begins Tuesday in New York. http://www.ibtimes.com/articles/20080623/jefferies-opens-annual-health-care-conference-tuesday.htm Mon, 23 Jun 2008 16:39:07 EDT Biopharmaceutical company Celgene Corp. said Monday that patients with the blood cancer multiple myeloma treated with the drug Revlimid plus a standard drug survived longer than those just taking the standard drug. http://www.ibtimes.com/articles/20080616/celgene-cancer-drug-shows-survival-benefit.htm Mon, 16 Jun 2008 12:02:31 EDT With research and development pipelines lagging and patent expirations on many key drugs looming, large pharmaceutical and biotech companies are increasingly looking to biotechnology acquisitions as a way to bring new drugs forward. http://www.ibtimes.com/articles/20080612/market-spotlight-biotech-acquisition-trends.htm Thu, 12 Jun 2008 11:22:40 EDT